Skip to main content

How Computational Methods Try to Disclose the Estrogen Receptor Secrecy - Modeling the Flexibility

Buy Article:

$63.00 plus tax (Refund Policy)


The Estrogen Receptor (ER) is a ligand activated transcription factor involved in numerous fundamental biological processes as in many important diseases and malfunctions. Since 1998, when the first structure of the ER ligand binding domain complexed with 17 β-estradiol (E2) was released, the number of ERα and ERβ crystallographic structures constantly increased. Nevertheless, little is still known about several fundamental events that govern the regular biological activity, or that modulate the transcription response following the interaction of the receptor with xenobiotic compounds. Moreover, the peculiar flexibility of the receptor characterized by two levels of conformational changes, i.e slight adjustments of binding pocket residues side chains, and more significant displacement of helix 12, moving from a close/agonistlike to an open/antagonist-like position, makes experimental approaches unable to properly describe and predict the receptor conformational equilibrium. Which is the most probable structure of the unbound receptor? How do biological ligands enter the receptor? How does the tissue-related pull of coactivators and corepressors affect the puzzling conformational equilibrium of the receptor? Since most of these questions still do not have an answer. A proper description of the structure- activity relationship and of the pharmacophoric properties of the binding pocket would be of paramount importance in order to design new agonist and antagonist molecules, and to understand how diverse xenobiotic compounds can alter the conformational equilibrium of the receptor, inducing estrogenic or anti-estrogenic effects. In this review we report the most relevant computational approaches, both theoretical and applicative, and the latest proposed models.

Keywords: Estrogen Receptor; SERMs; docking; drug design; flexibility; molecular modeling; scoring functions

Document Type: Research Article


Affiliations: Department of General and Inorganic Chemistry, University of Parma, viale G. Usberti 17/A, 43100, Parma, Italy.

Publication date: 2009-08-01

More about this publication?
  • Current Medicinal Chemistry covers all the latest and outstanding developments in medicinal chemistry and rational drug design. Each issue contains a series of timely in-depth reviews written by leaders in the field covering a range of the current topics in medicinal chemistry. Current Medicinal Chemistry is an essential journal for every medicinal chemist who wishes to be kept informed and up-to-date with the latest and most important developments.
  • Access Key
  • Free content
  • Partial Free content
  • New content
  • Open access content
  • Partial Open access content
  • Subscribed content
  • Partial Subscribed content
  • Free trial content
Cookie Policy
Cookie Policy
Ingenta Connect website makes use of cookies so as to keep track of data that you have filled in. I am Happy with this Find out more